HIV

An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment. An experimental drug originally developed to treat cancer may

Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women. Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study

Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need for lifelong medications. Researchers in George Mason University's Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study in Nature's Gene Therapy that found an HIV-like virus particle that could cease

Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than adults. Experts long assumed that testing for viral drug resistance could improve treatment in cases where treatment has failed. However, a research team now shows

A new study has found a startling disparity in the frequency of liver disease for transgender individuals and highlights the need for more specialized care. Cirrhosis is chronic, progressive end-stage liver disease that occurs when scar tissue prevents the liver from functioning normally. Studies have shown that two of the leading causes of cirrhosis --

A major challenge in developing a vaccine for HIV is that the virus mutates fast -- very fast. Although a person initially becomes infected with one or a few HIV strains, the virus replicates and mutates quickly, resulting in a 'swarm' of viral strains existing in a single body. A major challenge in developing a

Burnham Prebys Medical Discovery Institute have discovered that certain HIV drugs may have the potential to reduce the risk of developing Alzheimer's disease. This groundbreaking research offers hope for a future where existing medications can be repurposed to combat one of the most devastating neurodegenerative diseases. With the potential to impact millions of lives, this discovery represents a significant advancement in the field of Alzheimer's research

Study found that PLWH have significantly higher levels of a type of sugar called glycated albumin, which has been linked to accelerated aging and inflammation in the body. This discovery could lead to new treatments and interventions to improve the overall health and well-being of PLWH. The research conducted by Dr. Abdel-Mohsen and his team is a groundbreaking step towards understanding the underlying mechanisms of aging and inflammation in this population, and has the potential to make a significant impact on the development of targeted therapies in the future